Market Chameleon (Wed, 7-Jan 3:40 AM ET)
Business Wire (Wed, 7-Jan 6:30 AM ET)
Business Wire (Tue, 6-Jan 6:30 AM ET)
Business Wire (Tue, 9-Dec 6:30 AM ET)
Compass Pathways to Participate in Two Investor Conferences in December
Business Wire (Thu, 20-Nov 6:30 AM ET)
Compass Pathways to Participate in Stifel 2025 Healthcare Conference
Business Wire (Wed, 5-Nov 6:30 AM ET)
Market Chameleon (Tue, 4-Nov 6:25 AM ET)
CMPS Accelerates Commercial Launch Plans as Positive FDA Talks and Phase 3 Milestones Fuel Outlook
Market Chameleon (Tue, 4-Nov 2:06 AM ET)
Business Wire (Tue, 4-Nov 6:30 AM ET)
PRNewswire (Thu, 30-Oct 8:30 AM ET)
Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
Compass Pathways PLC - American Depository Shares trades on the NASDAQ stock market under the symbol CMPS.
As of January 20, 2026, CMPS stock price climbed to $7.39 with 764,877 million shares trading.
CMPS has a beta of 0.70, meaning it tends to be less sensitive to market movements. CMPS has a correlation of 0.02 to the broad based SPY ETF.
CMPS has a market cap of $691.42 million. This is considered a Small Cap stock.
In the last 3 years, CMPS traded as high as $12.75 and as low as $2.25.
The top ETF exchange traded funds that CMPS belongs to (by Net Assets): ARKG, IBB, PSIL, GWX, BBC.
CMPS has outperformed the market in the last year with a price return of +116.7% while the SPY ETF gained +16.3%. CMPS has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +15.3% and +12.8%, respectively, while the SPY returned +3.4% and -0.3%, respectively.
CMPS support price is $7.01 and resistance is $7.69 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CMPS shares will trade within this expected range on the day.
